The Lancet Neurology in conversation with

Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis

September 20, 2023 The Lancet Group
Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis
The Lancet Neurology in conversation with
More Info
The Lancet Neurology in conversation with
Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis
Sep 20, 2023
The Lancet Group

Anthony Feinstein (University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Canada) discusses CogEx, a randomised trial of cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis. The Article is published in the October issue of The Lancet Neurology.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Show Notes

Anthony Feinstein (University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Canada) discusses CogEx, a randomised trial of cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis. The Article is published in the October issue of The Lancet Neurology.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv